Synthetic Biology Market Size Expected To Gain USD 30.7 Billion, At A 26.5% CAGR By 2026

Thermo Fisher Scientific (US) held the leading position in the synthetic biology market. The company offers synthetic biology products, which include DNA fragments, software, engineering kits, DNA oligos, and clones.

The report "Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Gene Synthesis, Genome Engineering), Application(Tissue Regeneration, Biofuel, Consumer Care, Food Agriculture, Environmental) and Region - Global Forecast to 2026" The global synthetic biology market size is projected to reach USD 30.7 billion by 2026 from USD 9.5 billion in 2021, at a CAGR of 26.5% during the forecast period.

Factors such as a wide range of applications of synthetic biology, the rising RD funding and growing initiatives in synthetic biology, declining cost of DNA sequencing and synthesizing, and increasing investments in the market are propelling the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889

The oligonucleotides and synthetic DNA segment accounted for the largest share of the tool segment in the synthetic biology market.

On the basis of tool, the synthetic biology market is broadly segmented into oligonucleotides synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. oligonucleotides synthetic DNA  accounted for the largest share of the synthetic biology market for tools.

The medical applications segment accounted for the largest share of the application segment in the synthetic biology market

Based on application, the synthetic biology market is categorized into three segments—medical applications, industrial applications, food agriculture, and environmental applications. medical applications segment accounted for the largest share of synthetic biology market.

The Asia Pacific region is the fastest-growing region of the synthetic biology market

The Asia Pacific region is estimated to grow at the highest CAGR in the synthetic biology market during the forecast period, this is mainly due to factors such the growing collaborations in the field of synthetic biology, growing partnerships in the Chinese market, and investments in Asia Pacific countries for research.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=889

Key Market Players

Some of the prominent players in the synthetic biology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), and Eurofins Scientific (Luxembourg).

This report categorizes the synthetic biology market into the following segments and subsegments:

By Tool

  • Oligonucleotides and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Synthetic Cells
  • Chassis Organisms
  • Xeno-nucleic Acids

By Technology

  • Gene Synthesis
  • Genome Engineering
  • Sequencing
  • Bioinformatics
  • Site-directed Mutagenesis
  • Cloning
  • Measurement and Modelling
  • Microfluidics
  • Nanotechnology

By Application

  • Medical Application
  • Artificial Tissue and Tissue Regeneration
  • Industrial Applications
  • Food Agriculture
  • Environmental Applications

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=889

Don’t miss out on business opportunities in Synthetic Biology Market. Speak to our analyst and gain crucial industry insighs that will help your businessgrow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

[email protected]


johnny andrew

120 Blog posts

Comments